Global Defibrillators Market Report 2021-2027 with Medtronic, Boston Scientific, Philips Healthcare, Nihon Kohden, and Asahi Kasei


DUBLIN, December 6, 2021 / PRNewswire / – The “Defibrillators Market Size, Share, Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Business Analysis of Opportunities” report has been added to offer.

The global defibrillator market will be $ 18.01 billion by 2027 from $ 12.87 billion in 2021, increasing at a CAGR of 5.76% during 2021-2027

Around the world, different types of defibrillators work in different ways. Say, for example, Automated External Defibrillators (AEDs) can be seen in many public places to save the lives of people with sudden cardiac arrest. Even untrained people or passers-by can use these devices in an emergency.

Defibrillators are extremely helpful in rekindling sudden cardiac arrest; this further pushed the demand for defibrillators in the pandemic situation. Most likely, its timely favorable regulation and increasing demand for adoption will lead to lucrative growth of this market in the years to come.

The driving force behind the growth of the global Defibrillator market is the awareness of the importance of good heart health, increasing technological advancements across the globe, cases of heart disorders, and legislative reforms. Nonetheless, the lack of advanced healthcare infrastructure, high costs, and low reimbursement policies are hampering the growth of the defibrillator market globally.

Impact of COVID-19 on the medical defibrillator market

COVID-19 can affect the cardiovascular system, causing myocardial damage, arrhythmias, intravascular thrombosis, and sudden cardiac death. The first reports recommended a temporary association between COVID-19 activity and cardiac arrests in the community and in hospitals.

Life-threatening arrhythmias have been variably reported in patients hospitalized with COVID-19 infection. Sudden cardiac arrest (SCA) in COVID-19 patients is an alarming concern for clinicians. Episodes of defibrillator shock increased during higher COVID-19 activity. Read the full on-time COVID-19 Defibrillator Market Performance.

American Heart Association on Defibrillators

The American Heart Association said about 20,000 lives are saved through the availability of defibrillators each year and suggested that public access defibrillators (PADs) should be available in residential apartments, transportation hubs and institutions. public.

By product type, we have categorized the Global Defibrillators Market into Implantable Cardiac Defibrillators and External Defibrillators Market. In this case, the market for external defibrillators will grow rapidly during the forecast period. External defibrillators are lifesaving devices used to deliver defibrillation shock to diagnose and restore heart rhythms during unexpected cardiac arrest. Apart from this, the Implantable Cardiac Defibrillator market will also thrive in 2020-2027.

North America holds the lion’s share of the global defibrillator market

This report segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa depending on the region. On which North America holds the lion’s share of the global defibrillator market.

Likewise, Asia Pacific countries like China and India have huge population and at the same time these countries provide immense opportunities for market players and are expected to be the fastest growing region during the forecast period.

Business analysis
1. Medtronic Plc
2. Boston Scientific Society
3. Philips Health
4. Nihon Kohden Corporation
5. Asahi Kasei Corporation

Main topics covered:

1. Introduction

2. Research methodology

3. Executive summary

4. Market dynamics
4.1 Growth drivers
4.2 challenges

5. Global Defibrillator Market

6. Market share
6.1 Product type
6.2 Implantable cardioverting defibrillator
6.3 Transvenous implantable cardiac defibrillators
6.4 By external defibrillators
6.5 By end users
6.6 By regions

7. Product Type – Global Defibrillator Market
7.1 Implantable cardioverting defibrillator
7.2 External defibrillator

8. Implantable Cardioverter Defibrillator – Global Defibrillator Market
8.1 Transvenous implantable cardiac defibrillators (T-ICD)
8.1.1 Implantable Single-Chamber Cardioverter Defibrillators
8.1.2 Double-chamber implantable cardioverting defibrillators
8.1.3 Biventricular Implantable Cardiac Defibrillators / Cardiac Resynchronization Therapy Defibrillators (CRT-D)
8.2 Implantable subcutaneous cardiac defibrillators (S-ICD)
8.3 Others

9. External Defibrillators – Global Defibrillators Market
9.1 Automated external defibrillators
9.2 Advanced resuscitation defibrillators
9.3 Portable cardioverter defibrillators

10. End Users – Global Defibrillator Market
10.1 Hospital
10.2 Prehospital
10.3 Public access market
10.4 Alternative care market
10.5 Home care

11. By Region – Global Defibrillator Market
11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 Latin America
11.5 Middle East and Africa

12. Business analysis
12.1 Overview
12.2 Recent developments and strategies
12.3 Financial information

  • Medtronic Plc
  • Boston Scientific Society
  • Philips Health
  • Nihon Kohden Corporation
  • Asahi Kasei Company

For more information on this report visit

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links


Comments are closed.